However, the encouraging clinical effects under the continuous treatment with drisapersen compared with placebo did not reach statistical significance by week 49. 86 , 87 A subsequent and larger double-blind phase III study investigated 186 patients randomized to drisapersen (6 mg/kg/week) or to placebo for 48 weeks.
1
—
—